Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Pfizer, Inc.
  6. Company
    PFE   US7170811035

PFIZER, INC.

(PFE)
  Report
Delayed Quote. Delayed Nyse - 09/24 04:10:00 pm
43.94 USD   -0.57%
09/25PFIZER : Israel says US booster plan supports its own aggressive push
AQ
09/25AP NEWS IN BRIEF AT 12 : 04 a.m. EDT
AQ
09/24PFIZER : Guest lineups for the Sunday news shows
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Pfizer, Inc.
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Number of employees : 78 500 people.
Sales per Business
2020
Oncology10 867.0025.9%
Internal Medicine9 003.0021.5%
Hospital7 961.0019%
Vaccines6 575.0015.7%
Inflammation & Immunology4 567.0010.9%
Rare Disease2 936.007%
USD in Million
Sales per region
20192020Delta
United States23 852.0046.1%21 712.0051.8% -8.97%
Developed Europe8 701.0016.8%7 788.0018.6% -10.49%
Emerging Markets8 075.5015.6%5 857.5214% -27.47%
Japan4 140.008%2 514.486% -39.26%
China4 657.509%2 514.486% -46.01%
Developed Rest of World2 325.004.5%1 521.523.6% -34.56%
USD in Million
Managers
Name Title Age Since
Albert Bourla Chairman, Chief Executive & Operating Officer 58 2020
Frank D'Amelio Chief Financial Officer & EVP-Global Supply 62 2007
Mikael Dolsten Chief Scientific Officer & Research President 61 2019
Lidia Fonseca Executive VP, Chief Digital & Technology Officer 51 -
Aida Habtezion Chief Medical Officer - -
Rady Johnson Executive VP, Chief Compliance & Risk Officer 59 2013
Suzanne Nora Johnson Independent Director 63 2007
Helen H. Hobbs, Dr. Independent Director 67 2011
Shantanu Narayen Lead Independent Director 56 -
James Smith Independent Director 60 2014
Members of the board
Name Title Age Since
Albert Bourla Chairman, Chief Executive & Operating Officer 58 2020
Suzanne Nora Johnson Independent Director 63 2007
Helen H. Hobbs, Dr. Independent Director 67 2011
Shantanu Narayen Lead Independent Director 56 -
James Smith Independent Director 60 2014
Joseph Echevarria Independent Director 63 2015
Ronald E. Blaylock Independent Director 60 2017
Dan R. Littman, Dr. Independent Director 67 2018
Scott Gottlieb, Dr. Independent Director 47 2019
James R. Quincey Independent Director 55 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,457,688,356 5,604,412,993 59.3% 3,851,000,000 40.7% 59.3%
Shareholders
NameEquities%
The Vanguard Group, Inc. 432,721,863 7.72%
SSgA Funds Management, Inc. 278,568,311 4.97%
Wellington Management Co. LLP 241,721,238 4.31%
Capital Research & Management Co. (World Investors) 240,189,415 4.28%
Capital Research & Management Co. 142,320,700 2.54%
BlackRock Fund Advisors 121,450,367 2.17%
Geode Capital Management LLC 96,381,189 1.72%
Northern Trust Investments, Inc.(Investment Management) 64,250,392 1.15%
Norges Bank Investment Management 60,296,992 1.08%
State Farm Investment Management Corp. 56,536,168 1.01%
Holdings
NameEquities%Valuation
PFIZER LIMITED (500680) 29,243,042 63.9% 2,290,937,049 USD
SPRINGWORKS THERAPEUTICS, INC. (SWTX) 4,583,047 9.33% 344,186,830 USD
CORTEXYME, INC. (CRTX) 2,056,377 6.93% 198,029,105 USD
BIOATLA, INC. (BCAB) 2,238,090 6.93% 91,963,118 USD
MORPHIC HOLDING, INC. (MORF) 1,265,635 3.47% 79,747,661 USD
4D MOLECULAR THERAPEUTICS, INC. (FDMT) 1,666,658 6.18% 50,916,402 USD
SPERO THERAPEUTICS, INC. (SPRO) 2,362,348 7.35% 45,475,199 USD
SOSEI GROUP CORPORATION (4565) 1,885,136 2.32% 30,406,527 USD
NEXTCURE, INC. (NXTC) 1,970,759 7.14% 15,017,184 USD
RAQUALIA PHARMA INC. (4579) 743,000 3.55% 7,148,656 USD
Markets and indexes
- International Market
- DJIA / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  PFIZ11B:BZ
- Reuters Code :  
- Datastream Code :  
Company contact information
Pfizer, Inc.
235 Street East 42nd
NY 10017 New York City, New York

Phone : +1 212 573 2323
Fax : +1 212 573 7851
web site : http://www.pfizer.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Pfizer, Inc.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
PFIZER, INC.20.05%246 358
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037
ABBVIE INC.-0.07%189 211
ASTRAZENECA PLC20.77%187 304
MERCK & CO., INC.-10.01%186 334
NOVARTIS AG-8.00%186 020
BRISTOL-MYERS SQUIBB COMPANY-2.90%133 838
AMGEN INC.-7.09%121 299
SANOFI4.22%120 553
GLAXOSMITHKLINE PLC3.43%94 962
CHUGAI PHARMACEUTICAL CO., LTD.-21.79%63 921
ALLERGAN PLC0.97%63 659
TAKEDA PHARMACEUTICAL COMPANY LIMITED0.43%53 563
BAYER AG-3.45%53 487
DAIICHI SANKYO COMPANY, LIMITED-12.98%53 247
JIANGSU HENGRUI MEDICINE CO., LTD.-46.38%49 081
ASTELLAS PHARMA INC.19.35%31 844
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY50.88%24 932